Bio Pharma Dive
OCTOBER 26, 2023
Executives at the biotech say they’re trying to get ahead of the payer and production challenges that will face their gene editing treatment exa-cel, which is now under FDA review.
Pharmaceutical Technology
OCTOBER 26, 2023
The potential for using gene therapies to treat sickle cell disease is high, but their durability and high price point invite scrutiny.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
OCTOBER 26, 2023
The partners announced the trial had succeeded weeks after Moderna disclosed positive results from a study of its similar combination vaccine.
Pharmaceutical Technology
OCTOBER 26, 2023
The EC announced new initiatives to tackle critical medicine shortages in winter, introducing more flexibility to strengthen supplies.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
AuroBlog - Aurous Healthcare Clinical Trials blog
OCTOBER 26, 2023
Many tiny organisms including bacteria, fungi and viruses normally live on our bodies, and even inside us. These are called the microbiome. The large number of these organisms living in the gastrointestinal tract are collectively known as the gut microbiome.
Pharmaceutical Technology
OCTOBER 26, 2023
A pivotal Phase III trial will be initiated in the coming months to further evaluate the lead formulations of the combination vaccine.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
AuroBlog - Aurous Healthcare Clinical Trials blog
OCTOBER 26, 2023
The Indian Council of Medical Research (ICMR) has invited proposals to establish Ayush-ICMR Advanced Centre for Integrative Health Research (AI-ACIHR) at the All India Institute of Medical Sciences (AIIMS) under Extramural Programme. This is following a Memorandum of Agreement (MoA) signed between the Union Ministry of Ayush and the ICMR at an inter-ministerial level.
Bio Pharma Dive
OCTOBER 26, 2023
Backed by like Atlas, Cormorant and OrbiMed, Triveni is developing an antibody drug for eczema and asthma that takes aim at a different kind of target.
Pharma Times
OCTOBER 26, 2023
Thousands of patients with heart failure are set to benefit from the expansion - News - PharmaTimes
Bio Pharma Dive
OCTOBER 26, 2023
Company shares fell Thursday as the company adjusted its medium-term guidance for sales of new products like Reblozyl, Camzyos and Abecma.
Pharmaceutical Technology
OCTOBER 26, 2023
MK-1942 was in two Phase II trials for the treatment of Alzheimer’s disease and major depressive disorder.
Fierce Pharma
OCTOBER 26, 2023
Novartis believes a former employee of its Egyptian affiliate made off with thousands of files before jumping ship to Takeda. | Novartis believes a former employee of its Egyptian affiliate made off with thousands of files before jumping ship to Takeda. Now, the Swiss pharma giant wants a peek at Takeda’s business records to find out whether its confidential information has been used improperly.
Pharmaceutical Technology
OCTOBER 26, 2023
The Series A funds will go towards the clinical development of TRIV-509, with plans for a proof-of-concept atopic dermatitis study.
Pharma Times
OCTOBER 26, 2023
The two projects will be awarded $1m each to support their clinical investigations - News - PharmaTimes
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharmaceutical Technology
OCTOBER 26, 2023
Sanguinate is under clinical development by Prolong Pharmaceuticals and currently in Phase II for Sickle Cell Disease With Vaso-Occlusive Crisis.
Fierce Pharma
OCTOBER 26, 2023
With concerns growing over the burden Leqembi could impose on healthcare infrastructure, Eisai and Biogen have trotted out data for an under-the-skin version of the Alzheimer’s disease drug that ma | Eisai and Biogen have trotted out data for a subcutaneous version of the Alzheimer’s disease drug Leqembi. The self-injected version showed an encouraging efficacy result but a seemingly increased risk of ARIA, which analysts said shouldn't be too much of a concern.
Pharmaceutical Technology
OCTOBER 26, 2023
NKTR-255 is under clinical development by Nektar Therapeutics and currently in Phase III for Diffuse Large B-Cell Lymphoma.
pharmaphorum
OCTOBER 26, 2023
COVID, flu combo jab from Pfizer/BioNTech heads for phase 3 Phil.
Pharmaceutical Technology
OCTOBER 26, 2023
The FDA has approved Tofidence as the first biosimilar referencing the IL-6 receptor antagonist tocilizumab for rheumatoid arthritis
pharmaphorum
OCTOBER 26, 2023
The longitudinal history of medicines innovation: Part One Mike.
Pharmaceutical Technology
OCTOBER 26, 2023
Flashpoint Therapeutics has secured $10m in a seed funding round to develop nanotechnology-enabled medicines.
Fierce Pharma
OCTOBER 26, 2023
It’s been grounded in Europe and reduced to irrelevancy in the U.S., but Merck’s COVID-19 pill Lagevrio somehow remains a force. | It’s been grounded in Europe and reduced to irrelevancy in the U.S., but Merck’s COVID-19 pill Lagevrio somehow remains a force. The antiviral treatment racked up sales of $640 million in the third quarter, shocking analysts who figured it would generate $120 million.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Pharmaceutical Technology
OCTOBER 26, 2023
The ACIP of the US Centers for Disease Control and Prevention recommended routine use of Bavarian Nordic’s mpox vaccine, Jynneos, in adults.
pharmaphorum
OCTOBER 26, 2023
NICE backs pump-based Parkinson’s drug from AbbVie Phil.
Pharmaceutical Technology
OCTOBER 26, 2023
GSK plans to submit the data to regulatory agencies to support label expansion for Arexvy in the younger adult patient population in 2024.
Rethinking Clinical Trials
OCTOBER 26, 2023
Speakers Rachael L. Fleurence, PhD, MSc Senior Advisor National Institutes of Health Joshua M. Sharfstein, MD Vice Dean for Public Health Practice and Community Engagement Director, Bloomberg American Health Initiative Professor of the Practice in Health Policy and Management Slides Keywords Hepatitis C, NIH, PCORnet Key Points The advances in Hepatitis C drugs is one of the greatest successes in clinical research in the last 20 years, yet Hepatitis C is a public health crisis in th
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Pharmaceutical Technology
OCTOBER 26, 2023
Zenith Epigenetics and Cencora have signed an agreement for expediting the commercialisation of the former’s ZEN-3694 programme.
Fierce Pharma
OCTOBER 26, 2023
On outgoing chief executive Giovanni Caforio’s last earnings call, Bristol Myers Squibb had some tough questions to answer about a roster of underperforming new products. | On outgoing chief executive Giovanni Caforio’s last earnings call, Bristol Myers Squibb had some tough questions to answer about a roster of underperforming new products. But according to CEO-elect Chris Boerner, it’s a question of “when, not if” those drugs rise to meet expectations.
Pharmaceutical Technology
OCTOBER 26, 2023
Appili Therapeutics has received additional funding of $6.6m from the US Air Force Academy to develop ATI-1701.
pharmaphorum
OCTOBER 26, 2023
How to leverage real-world data for better patient care Mike.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Expert insights. Personalized for you.
313 
Let's personalize your content